Indaptus Therapeutics, Inc.
INDP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$15,022 | -$15,423 | -$14,323 | -$7,711 |
| Dep. & Amort. | $1 | $1 | $2 | $1 |
| Deferred Tax | $0 | $0 | $0 | -$5,750 |
| Stock-Based Comp. | $2,306 | $2,966 | $2,957 | $1,510 |
| Change in WC | $392 | -$518 | -$1,580 | -$5,091 |
| Other Non-Cash | $0 | -$431 | -$134 | $5,750 |
| Operating Cash Flow | -$12,323 | -$13,405 | -$13,078 | -$11,291 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$173 | -$4 |
| Net Acquisitions | $0 | $0 | $173 | $452 |
| Inv. Purchases | $0 | -$6,859 | -$29,600 | $0 |
| Inv. Sales/Matur. | $0 | $24,000 | $13,000 | $0 |
| Other Inv. Act. | $0 | $0 | $173 | $0 |
| Investing Cash Flow | $0 | $17,141 | -$16,427 | $448 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $5,511 | $0 | $0 | $5,000 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$763 | $0 | $0 | $43,337 |
| Financing Cash Flow | $4,748 | $0 | $0 | $48,337 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$7,575 | $3,735 | -$29,505 | $37,495 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $13,362 | $9,627 | $39,132 | $1,637 |
| End Cash | $5,787 | $13,362 | $9,627 | $39,132 |
| Free Cash Flow | -$12,323 | -$13,405 | -$13,251 | -$11,294 |